Delivery Order SPE2DB22D1017-SPE2DB25FF5TU

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,970.36, is for the supply of Cyclosporine 0.05% eye emulsion, which is a critical pharmaceutical product used in the treatment of various eye conditions. The contract has an ultimate completion date of January 15, 2025 and is part of a larger Indefinite Delivery Contract...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclosporine 0.05% eye emulsion, a specialty medication. The contract has a ceiling value of $5,621.71 and a completion date of December 5, 2024. It is a Firm Fixed Price contract, which indicates a predetermined price for the goods or services. The contract was not set aside for any...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cyclosporine 0.05% eye emulsion, a medical product used for the treatment of certain eye conditions. The award has a ceiling value of $1,540.71 and a final completion date of December 13, 2023. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract has a total ceiling value of $18,195.35 and a performance period through January 16, 2025. The contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,584.83, is for the supply of Cyclosporine 0.05% eye emulsion. The contract is a firm fixed-price type, with a period of performance through January 18, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract has a ceiling value of $2,772.90 and an ultimate completion date of April 26, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract has a ceiling value of $4,820.52 and is a firm fixed-price delivery order, with a period of performance through December 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The delivery order is valued at $1,456.32 and has a completion date of June 8, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a $2,658.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4563239582 - Cyclosporine 0.05% Eye Emulsion, 60s, with a performance period ending on January 5, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which provides a wide...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a global pharmaceutical distribution company. The contract is for the supply of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product, with a ceiling value of $5,146.94 and a period of performance through March 22, 2024. Amerisourcebergen Drug Corporation serves as the prime contractor, providing pharmaceutical and medical supply products to...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF5TU
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567315980 - Cyclosporine 0.05% Eye Emulsion, a pharmaceutical product, with a ceiling value of $3,681.86 and a completion date of February 20, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order contract is likely a task order under that broader IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 5/22/25, 8:33 PM